Pathologic Tumor Regression is Associated With Improved Survival in Pancreatic Cancer
CONCLUSION: Survival is significantly improved in those downstaged, as assessed by the CAP Tumor Regression Schema. Downstaging is an important prognostic variable that can help with joint decision making for clinicians and patients.PMID:37227766 | DOI:10.1177/00031348231175120
Source: The American Surgeon - Category: Surgery Authors: Laura M Nicolais Molly Caron Nicholas Verdini Timothy L Fitzgerald Source Type: research
More News: Abraxane | Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer | Pathology | Study | Surgery